Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Blood Pressure Drug Recalled for Impurities
10/11/2023
Jolynn Tumolo
Amerisource Health Services voluntarily initiated the recall September 1, 2023. The FDA designated the recall Class III on October 5, 2023. Per the Class III designation, use of the affected tablets is not likely to cause harm.
Amerisource Health Services voluntarily initiated the recall September 1, 2023. The FDA designated the recall Class III on October 5, 2023. Per the Class III designation, use of the affected tablets is not likely to cause harm.
Amerisource Health Services...
10/11/2023
Pharmacy Learning Network
News
Narcan, Now Available Without a Prescription, Can Still Be Hard to Get
10/11/2023
Jackie Fortiér, LAist and Nicole Leon...
Last month, drugstores and pharmacies nationwide began stocking and selling the country’s first over-the-counter version of naloxone, a medication that can stop a potentially fatal overdose from opioids, but it’s unclear whether the move will...
Last month, drugstores and pharmacies nationwide began stocking and selling the country’s first over-the-counter version of naloxone, a medication that can stop a potentially fatal overdose from opioids, but it’s unclear whether the move will...
Last month, drugstores and...
10/11/2023
Pharmacy Learning Network

Advertisement

News
Decreases in Opioid Prescribing by State Varied After CDC Guidance
10/06/2023
Jolynn Tumolo
Understanding state-level trends and variations in opioid prescribing may help inform future efforts to improve prescribing and reduce related harm, researchers advised.
Understanding state-level trends and variations in opioid prescribing may help inform future efforts to improve prescribing and reduce related harm, researchers advised.
Understanding state-level trends...
10/06/2023
Pharmacy Learning Network
News
Analytical Methods Used by the FDA for Drug Approvals in 2023
10/05/2023

Lisa Kuhns, PhD

Lisa Kuhns, PhD
Utilizing robust and diverse analytical methods in 2023, the FDA ensured rigorous assessment of drug quality, safety, and efficacy in drug approval, providing reliable and effective treatments for patients, according to a study published in...
Utilizing robust and diverse analytical methods in 2023, the FDA ensured rigorous assessment of drug quality, safety, and efficacy in drug approval, providing reliable and effective treatments for patients, according to a study published in...
Utilizing robust and diverse...
10/05/2023
Pharmacy Learning Network
News
Opioid Epidemic Linked to Higher Nonmarital Birth Rates Among Unmarried Women, Study Finds
10/05/2023

Lisa Kuhns, PhD

Lisa Kuhns, PhD
A study published in Demography suggests that the opioid epidemic primarily elevated the rates of nonmarital births among unmarried women due to social disruptions rather than being primarily driven by shifts in their economic circumstances.
A study published in Demography suggests that the opioid epidemic primarily elevated the rates of nonmarital births among unmarried women due to social disruptions rather than being primarily driven by shifts in their economic circumstances.
A study published in Demography...
10/05/2023
Pharmacy Learning Network

Advertisement

News
Postoperative Opioid Use Decreases After Hospital Adopts Analgesia Care Bundle
10/04/2023
Jolynn Tumolo
In a study published JAMA Network Open, researchers revealed that implementing a comprehensive care package comprising a personalized opioid treatment plan, routine gabapentinoid use, and clonidine as an emergency pain reliever resulted in a...
In a study published JAMA Network Open, researchers revealed that implementing a comprehensive care package comprising a personalized opioid treatment plan, routine gabapentinoid use, and clonidine as an emergency pain reliever resulted in a...
In a study published JAMA...
10/04/2023
Pharmacy Learning Network
News
Take-Home Methadone Linked With Reduced Overdose Deaths in Black, Hispanic Men
10/04/2023
Jolynn Tumolo
A study published in JAMA Health Forum found that, following a federal policy change permitting states to relax restrictions on take-home methadone doses for treatment-compliant patients, there was a reduction in monthly overdose deaths...
A study published in JAMA Health Forum found that, following a federal policy change permitting states to relax restrictions on take-home methadone doses for treatment-compliant patients, there was a reduction in monthly overdose deaths...
A study published in JAMA Health...
10/04/2023
Pharmacy Learning Network
News
Superpotent Prostate Cancer Drug Recalled
10/04/2023
Jolynn Tumolo
Tolmar Inc. is recalling a single lot of Eligard (leuprolide acetate) for superpotency.
Tolmar Inc. is recalling a single lot of Eligard (leuprolide acetate) for superpotency.
Tolmar Inc. is recalling a...
10/04/2023
Pharmacy Learning Network

Advertisement

News
Neonatal Outcomes Better With Buprenorphine in Pregnant Women With Opioid Use Disorder
10/04/2023
Jolynn Tumolo
The risk of adverse neonatal outcomes was lower in pregnant women with opioid use disorder treated with buprenorphine than methadone, according to a study published in The New England Journal of Medicine.
The risk of adverse neonatal outcomes was lower in pregnant women with opioid use disorder treated with buprenorphine than methadone, according to a study published in The New England Journal of Medicine.
The risk of adverse neonatal...
10/04/2023
Pharmacy Learning Network
News
Study Finds Variability of Cost-Effectiveness Ratios in Biologic Treatment Cases Due to Price Dynamics
10/04/2023

Lisa Kuhns, PhD

Lisa Kuhns, PhD
Cost-effectiveness ratios of biologic treatments varied with pre-loss of exclusivity (LOE) price increase, post-LOE price decrease, and comparator impact, according to a study published in Value in Health.
Cost-effectiveness ratios of biologic treatments varied with pre-loss of exclusivity (LOE) price increase, post-LOE price decrease, and comparator impact, according to a study published in Value in Health.
Cost-effectiveness ratios of...
10/04/2023
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use